Masaharu Kawashima

Minato, 1050003, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Plasmablastic lymphoma through clonal expansion 17 years after EBV-positive DLBCL: case report and review.

Plasmablastic lymphoma through clonal expansion 17 years after EBV-positive DLBCL: case report and review.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: May 31, 2026

Geriatric nutritional risk index for the prediction of venous thrombotic events in multiple myeloma.

Geriatric nutritional risk index for the prediction of venous thrombotic events in multiple myeloma.

Journal: International journal of clinical oncology

Published: April 11, 2026

Bronchiolitis obliterans complicating follicular lymphoma: a case series and clinical insights.

Bronchiolitis obliterans complicating follicular lymphoma: a case series and clinical insights.

Journal: International journal of hematology

Published: August 22, 2025

Relative Dose Intensity of Daratumumab, Lenalidomide, and Dexamethasone in Multiple Myeloma.

Relative Dose Intensity of Daratumumab, Lenalidomide, and Dexamethasone in Multiple Myeloma.

Journal: Cancers

Published: November 27, 2024

Second-line anti-CD38 monoclonal antibody therapy mitigates the negative impact of functional high-risk status in myeloma patients.

Second-line anti-CD38 monoclonal antibody therapy mitigates the negative impact of functional high-risk status in myeloma patients.

Journal: International journal of hematology

Published: September 06, 2024

Thrombocytopenia With High C-reactive Protein in Myeloma Patients Treated With Proteasome Inhibitor and/or Immunomodulatory Drugs.

Thrombocytopenia With High C-reactive Protein in Myeloma Patients Treated With Proteasome Inhibitor and/or Immunomodulatory Drugs.

Journal: Cancer diagnosis & prognosis

Published: August 15, 2024

Safety and efficacy of automatic subcutaneous injection of daratumumab via an infusion pump.

Safety and efficacy of automatic subcutaneous injection of daratumumab via an infusion pump.

Journal: International journal of hematology

Published: August 06, 2024

Comparative analyses of immune cells and alpha-smooth muscle actin-positive cells under the immunological microenvironment between with and without dense fibrosis in primary central nervous system lymphoma.

Comparative analyses of immune cells and alpha-smooth muscle actin-positive cells under the immunological microenvironment between with and without dense fibrosis in primary central nervous system lymphoma.

Journal: Brain tumor pathology

Published: February 24, 2024

Contribution of post-transplantation therapy to sustained MRD negativity in multiple myeloma: a retrospective analysis.

Contribution of post-transplantation therapy to sustained MRD negativity in multiple myeloma: a retrospective analysis.

Journal: International journal of hematology

Published: July 25, 2023

Ⅱ. Treatment Strategy for Primary Testicular Lymphoma

Ⅱ. Treatment Strategy for Primary Testicular Lymphoma

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: May 23, 2023

Significance of trogocytosis and exosome-mediated transport in establishing and maintaining the tumor microenvironment in lymphoid malignancies.

Significance of trogocytosis and exosome-mediated transport in establishing and maintaining the tumor microenvironment in lymphoid malignancies.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: July 01, 2021

Expression of ERV3-1 in leukocytes of acute myelogenous leukemia patients.

Expression of ERV3-1 in leukocytes of acute myelogenous leukemia patients.

Journal: Gene

Published: September 18, 2020

Showing 1-12 of 15

Last Updated: 09/26/2026